A detailed history of Nissay Asset Management Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nissay Asset Management Corp holds 74,266 shares of EW stock, worth $4.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
74,266
Previous 75,349 1.44%
Holding current value
$4.86 Million
Previous $7.2 Million 4.74%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $91,296 - $102,137
-1,083 Reduced 1.44%
74,266 $6.86 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $46,353 - $61,062
639 Added 0.86%
75,349 $7.2 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $160,569 - $202,331
2,602 Added 3.61%
74,710 $5.7 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $170,913 - $230,368
2,467 Added 3.54%
72,108 $5 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $201,733 - $233,749
-2,478 Reduced 3.44%
69,641 $6.57 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $180,748 - $205,697
-2,434 Reduced 3.26%
72,119 $5.97 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $148,279 - $189,832
-2,171 Reduced 2.83%
74,553 $5.56 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $185,003 - $240,973
2,246 Added 3.02%
76,724 $6.34 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $236,145 - $350,177
-2,730 Reduced 3.54%
74,478 $7.08 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $166,500 - $209,579
1,633 Added 2.16%
77,208 $9.09 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $553,974 - $680,581
5,208 Added 7.4%
75,575 $9.79 Million
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $209,113 - $249,428
2,032 Added 2.97%
70,367 $7.97 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $117,627 - $146,978
1,403 Added 2.1%
68,335 $7.08 Million
Q1 2021

May 11, 2021

SELL
$78.68 - $90.67 $105,981 - $122,132
-1,347 Reduced 1.97%
66,932 $5.6 Million
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $174,206 - $221,688
-2,430 Reduced 3.44%
68,279 $6.23 Million
Q3 2020

Oct 20, 2020

SELL
$67.19 - $87.44 $790,087 - $1.03 Million
-11,759 Reduced 14.26%
70,709 $5.64 Million
Q2 2020

Jul 27, 2020

BUY
$57.54 - $76.95 $3.14 Million - $4.19 Million
54,514 Added 195.01%
82,468 $5.7 Million
Q1 2020

May 05, 2020

BUY
$52.41 - $81.0 $84,537 - $130,653
1,613 Added 6.12%
27,954 $5.27 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $70,481 - $80,694
-983 Reduced 3.6%
26,341 $6.15 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $56,995 - $69,848
-926 Reduced 3.28%
27,324 $6.01 Million
Q2 2019

Aug 07, 2019

SELL
$55.74 - $64.41 $47,936 - $55,392
-860 Reduced 2.95%
28,250 $5.22 Million
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $80,646 - $107,860
-1,684 Reduced 5.47%
29,110 $5.57 Million
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $51,700 - $63,431
1,114 Added 3.75%
30,794 $4.72 Million
Q3 2018

Oct 30, 2018

BUY
$45.7 - $58.03 $27,008 - $34,295
591 Added 2.03%
29,680 $5.17 Million
Q2 2018

Aug 08, 2018

SELL
$42.45 - $51.3 $62,826 - $75,924
-1,480 Reduced 4.84%
29,089 $4.23 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $58,834 - $75,065
-1,582 Reduced 4.92%
30,569 $4.27 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $1.09 Million - $1.27 Million
32,151
32,151 $3.62 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.